Clinical Focus
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA issues complete response letter for sublingual epinephrine film Anaphylm
2
AbbVie submits FDA, EMA applications for upadacitinib (RINVOQ) in non-segmental vitiligo for 12 years and older
3
Pediatric respiratory infection patterns shift after COVID-19 pandemic
4
Steroid Safety, Growth Concerns, and When to Escalate Pediatric Therapy
5